Clinical outcomes of modified partial cystectomy in muscle-invasive bladder cancer: balancing tumor control and quality of life
MPC surpasses LPC in tumor resection, reducing recurrence and enhancing survival. MPC also achieves similar oncological results to RC, making it a promising bladder-preserving alternative for MIBC patients.
Authors
- Ryan Michael Antar (ORCID: https://orcid.org/0000-0003-0947-407X)
- Osama Mahmoud (ORCID: https://orcid.org/0000-0002-3634-9541)
- Yunpeng Cheng (ORCID: https://orcid.org/0000-0002-1589-1921)
- Jinhai Wu
- Sian Chen (ORCID: https://orcid.org/0000-0002-0422-0620)
- Xuejin Zhu (ORCID: https://orcid.org/0000-0001-6251-1197)
- Jian Zhang (ORCID: https://orcid.org/0000-0001-8338-9426)
- Ran Xu (ORCID: https://orcid.org/0000-0003-1387-6696)
- Bin Wang (ORCID: https://orcid.org/0000-0002-5474-1002)
- Arjun Pon Avudaiappan
- Yanfei Chen (ORCID: https://orcid.org/0000-0002-2185-9303)
Institutions
- Jinan University (CN)
- South Valley University (EG)
- George Washington University (US)
- Essen University Hospital (DE)
- Miami Heart Research Institute (US)
- Guangzhou Medical University Cancer Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Translational Andrology and Urology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.21037/tau-2025-243
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00